Device Surgical Stapling

Dfs

Payments companies reported to CMS as associated with Dfs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3,401associated payments (2023-2025)

14clinicians with associated payments

1company reporting

By year

2023 $3,401

Payments reported as associated with Dfs, per program year, as reported to CMS.

Who makes it

Medtronic, INC. $3,401 associated with Dfs (2023-2025)

Specialties most often involved

Surgery $1,901

Vascular & Interventional Radiology $667

Surgical Oncology $333

Hematology & Oncology $167

Medical Oncology $167

Physician Assistant $167

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Dfs

These are the largest totals companies reported as associated with Dfs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Jorge Pelet Mejias	San Juan, PR	Surgery	$827.49
Diego Camacho	Mcallen, TX	Surgery	$573.11
Ghassan El Haddad	Tampa, FL	Vascular & Interventional Radiology	$166.67
Tiago Biachi De Castria	Tampa, FL	Medical Oncology	$166.67
Erez Klein	Tampa, FL	Vascular & Interventional Radiology	$166.67
Vaiva Gustainyte	Tampa, FL	Vascular & Interventional Radiology	$166.67
Richard Kim	Tampa, FL	Hematology & Oncology	$166.67
Ji Fan	Tampa, FL	Surgery	$166.67
Jason Denbo	Minneapolis, MN	Surgical Oncology	$166.67
Kelly Terranova	Tampa, FL	Physician Assistant	$166.67

Prescribed Dfs?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.